Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AVEO > SEC Filings for AVEO > Form 8-K on 2-Dec-2013All Recent SEC Filings

Show all filings for AVEO PHARMACEUTICALS INC

Form 8-K for AVEO PHARMACEUTICALS INC


2-Dec-2013

Change in Directors or Principal Officers


Item 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

(b) and (c) On November 26, 2013, David Johnston, the Company's Chief Financial Officer, provided notice to AVEO Pharmaceuticals, Inc. ("AVEO") of his intention to resign from the Company effective as of December 30, 2013 to pursue a new career opportunity. AVEO is in the process of commencing an external search for its next Chief Financial Officer. Effective as of December 30, 2013, Tuan Ha-Ngoc, AVEO's President and Chief Executive Officer, will assume the role of principal financial officer until a replacement Chief Financial Officer is appointed.


  Add AVEO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AVEO - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.